Vinicy Chan
Stories by Vinicy Chan
Sequoia-backed biotech firm Brii mulls Hong Kong IPO
The potential listing could raise about $200 million to $400 million.
Indonesia’s top drugmaker Kalbe Farma weighs food unit IPO
The company aims to list Kalbe Nutritionals on the Jakarta stock exchange as soon as this year.
Carlyle-backed Adicon Clinical Lab hires banks for Hong Kong IPO
The share sale could raise about $400 million.
China’s Tahoe Group to weigh sale of US healthcare unit
The sale of Alliance Healthcare could fetch $300-400 million.
Yum China targets second listing in Hong Kong in September
Yum China is part of a growing wave of US-listed Chinese firms looking for a trading foothold in HK.
Occidental in talks with Indonesia’s Pertamina for $4.5b energy asset sale
Pertamina is negotiating the acquisition of oil and gas stakes in countries including Ghana and the United Arab Emirates,
Nestle shortlists bidders for Yinlu food unit in China
PE firms FountainVest, Affinity Equity Partners and Citic Private Equity have been invited to participate.
China’s Tigermed receives Hong Kong exchange nod for listing in 2020
Shenzhen-listed Tigermed could raise $1 billion in what would be Asia’s largest healthcare listing this year.
Infra investor I Squared Capital weighs options for HK’s HGC Global
I Squared could also explore selling a stake in HGC Global or preparing an initial public offering.
China’s JD.com said to file for $2b Hong Kong second listing
The Beijing-based company, which currently trades on Nasdaq, has a market value of $64 billion.